CME Group (CME) Projected to Release Earnings on Wednesday

CME Group (NASDAQ:CME) is projected to issue its Q2 2026 results before the market opens on Wednesday, July 22nd. Analysts expect the company to announce earnings of $2.92 per share and revenue of $1.6821 billion for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, July 22, 2026 at 8:30 AM ET.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same quarter last year, the firm posted $2.80 EPS. The business’s revenue was up 14.5% on a year-over-year basis. On average, analysts expect CME Group to post $12 EPS for the current fiscal year and $13 EPS for the next fiscal year.

CME Group Price Performance

NASDAQ:CME opened at $245.05 on Monday. The stock has a 50 day moving average of $258.54 and a two-hundred day moving average of $282.15. CME Group has a 12 month low of $218.31 and a 12 month high of $329.16. The firm has a market cap of $88.80 billion, a P/E ratio of 20.91, a price-to-earnings-growth ratio of 3.05 and a beta of 0.25. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Tuesday, June 9th were given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 2.1%. The ex-dividend date was Tuesday, June 9th. CME Group’s payout ratio is presently 44.37%.

Insider Buying and Selling

In other news, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider owned 27,702 shares of the company’s stock, valued at $8,438,860.26. This represents a 17.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction on Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Raymond James Financial Inc. lifted its holdings in shares of CME Group by 5.4% in the 4th quarter. Raymond James Financial Inc. now owns 4,319,763 shares of the financial services provider’s stock worth $1,179,858,000 after acquiring an additional 222,890 shares during the last quarter. FIL Ltd increased its holdings in CME Group by 5.0% in the 4th quarter. FIL Ltd now owns 3,574,469 shares of the financial services provider’s stock valued at $976,116,000 after purchasing an additional 170,046 shares during the last quarter. Invesco Ltd. raised its position in CME Group by 23.0% in the third quarter. Invesco Ltd. now owns 2,830,323 shares of the financial services provider’s stock valued at $764,725,000 after purchasing an additional 528,358 shares during the period. AQR Capital Management LLC raised its position in CME Group by 1.7% in the third quarter. AQR Capital Management LLC now owns 2,431,787 shares of the financial services provider’s stock valued at $657,045,000 after purchasing an additional 39,607 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in CME Group by 1.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,148,161 shares of the financial services provider’s stock worth $586,620,000 after purchasing an additional 26,845 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CME. Barclays decreased their price objective on CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a report on Thursday, July 9th. Morgan Stanley reduced their target price on shares of CME Group from $353.00 to $324.00 and set an “overweight” rating for the company in a research report on Friday, July 10th. Weiss Ratings downgraded shares of CME Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 13th. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research report on Thursday, April 16th. Finally, Wall Street Zen cut shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 12th. Twelve investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, CME Group presently has an average rating of “Moderate Buy” and a consensus price target of $292.12.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.